Amexdrug Corp. (AXRX)
0.0002
0.00 (0.00%)
USD |
OTCM |
Oct 22, 16:00
Amexdrug EPS Diluted (Quarterly) : 0.0001 for March 31, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.0001 |
| December 31, 2025 | -0.0001 |
| September 30, 2025 | 0.0001 |
| June 30, 2025 | 0.0002 |
| March 31, 2025 | 0.0001 |
| December 31, 2024 | -0.0002 |
| September 30, 2024 | 0.0001 |
| June 30, 2024 | 0.0001 |
| March 31, 2024 | 0.0001 |
| December 31, 2023 | 0.0002 |
| September 30, 2023 | -0.0004 |
| June 30, 2023 | 0.0001 |
| March 31, 2023 | 0.0003 |
| September 30, 2022 | 0.0008 |
| June 30, 2022 | 0.0002 |
| March 31, 2022 | 0.0006 |
| December 31, 2021 | -0.0023 |
| September 30, 2021 | 0.0008 |
| June 30, 2021 | 0.0007 |
| March 31, 2021 | 0.0012 |
| December 31, 2020 | -0.0017 |
| September 30, 2020 | 0.0008 |
| June 30, 2020 | 0.0012 |
| March 31, 2020 | 0.0009 |
| December 31, 2019 | -0.0013 |
| Date | Value |
|---|---|
| September 30, 2019 | 0.0002 |
| June 30, 2019 | 0.0011 |
| March 31, 2019 | 0.0013 |
| December 31, 2018 | -0.0028 |
| September 30, 2018 | 0.0006 |
| June 30, 2018 | 0.0018 |
| March 31, 2018 | 0.0022 |
| December 31, 2017 | -0.0042 |
| September 30, 2017 | 0.0013 |
| June 30, 2017 | 0.0026 |
| March 31, 2017 | 0.0006 |
| December 31, 2016 | -0.002 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.0009 |
| March 31, 2016 | 0.0013 |
| December 31, 2015 | -0.0044 |
| September 30, 2015 | 0.0002 |
| June 30, 2015 | 0.0018 |
| March 31, 2015 | 0.0029 |
| December 31, 2014 | -0.0014 |
| September 30, 2014 | -0.0002 |
| June 30, 2014 | 0.0003 |
| March 31, 2014 | 0.0016 |
| December 31, 2013 | -0.0021 |
| September 30, 2013 | 0.0009 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cencora, Inc. | 3.937 |
| Cardinal Health, Inc. | 1.694 |
| McKesson Corp. | 5.151 |
| BIMI International Medical, Inc. | -- |
| Quick-Med Technologies, Inc. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.021M |
| Revenue (Quarterly) | 0.7366M |
| Total Expenses (Quarterly) | 0.7156M |
| Enterprise Value | -1.218M |
| Gross Profit Margin (Quarterly) | 55.53% |
| Profit Margin (Quarterly) | 2.85% |
| Earnings Yield | 150.0% |
| Operating Earnings Yield | 448.3% |
| Normalized Earnings Yield | 150.00 |